
South Africa: Boost for XDR-TB Patients As Cheaper Pills Allowed
The Medicines Control Council (MCC) has granted humanitarian group Medicines Sans Frontiers (MSF) access to a cheaper drug to treat extensively drug-resistant tuberculosis (XDR-TB).
The MCC's decision is the conclusion of a three-year battle for MSF and comes a few weeks after the MSF lodged a high court case against the MCC. This followed the regulatory body's failure to convene a statutory committee to allow MSF to appeal the.... Read more »
Posted on : Saturday , 6th September 2014